Folic acid in pregnancy and mortality from cancer and cardiovascular disease: further follow-up of the Aberdeen folic acid supplementation trial

BACKGROUND: Supplemental periconceptional folic acid is recommended to reduce the risk of fetal neural tube defects. A previous report indicated an elevated risk of breast cancer and all cancer deaths in later life among women randomised by alternate allocation to high-dose (5 mg/day) folic acid in...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Caroline M, Atkinson, Charlotte, Penfold, Chris, Bhattacharya, Sohinee, Campbell, Doris, Davey Smith, George, Leary, Sam, Ness, Andy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Other Topics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515996/
https://www.ncbi.nlm.nih.gov/pubmed/25855124
http://dx.doi.org/10.1136/jech-2014-205324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515996/
https://www.ncbi.nlm.nih.gov/pubmed/25855124
http://dx.doi.org/10.1136/jech-2014-205324

Ejemplares similares